Results 201 to 210 of about 2,192,035 (232)

Retraction Notice to: Therapeutic potential of IBP as an autophagy inducer for treating lung cancer via blocking PAK1/Akt/mTOR signaling. [PDF]

Mol Ther Oncol
Bu H, Tan S, Yuan B, Huang X, Jiang J, Wu Y, Jiang J, Li R.   +7 more
europepmc   +1 more source

Interpretable Machine Learning-Based Concentric Regional Analysis of OCTA Images for Enhanced Diabetic Retinopathy Detection. [PDF]

Bioengineering (Basel)
Osman SM, Alksas A, Balaha HM, Mahmoud A, Gamal A, Abdel-Hady ME, Abdelsalam MM, Khalil AT, Sewelam A, El-Baz A.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CPH 82

BioDrugs, 2003
CPH 82 [Reumacon] is a purified semi-synthetic lignan glycoside derivative of the medicinal herb Podophyllum emodi which inhibits microtubules. It has been jointly developed by the Swedish company Conpharm and the Swiss company Analytecon SA. It has potential for the treatment of rheumatoid arthritis.
openaire   +2 more sources

No. 82

Bezirk Schwetzingen, Amtsbezirk Philippsburg   +1 more
  +6 more sources

page 82

2023
  +9 more sources

Modeling 82 and polyblends 82

1982
The publication is stored in the NRC Archives.
openaire   +1 more source